Crispr Therapeutics shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Schonfeld Strategic Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 24k | 46.98 |
| 2023-12-31 | $1.1M | 17k | 62.60 |
| 2022-09-30 | $1.1M | 18k | 65.35 |
| 2021-06-30 | $1.7M | 10k | 161.81 |
| 2020-03-31 | $365k | 8.6k | 42.44 |
| 2019-09-30 | $1.1M | 26k | 40.99 |
| 2018-09-30 | $607k | 14k | 44.31 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors